Cargando…
Effect of Intensive and Standard Lipid-Lowering Therapy on the Progression of Stroke in Patients With Coronary Artery Syndromes: A Meta-Analysis of Randomized Controlled Trials
This meta-analysis demonstrated the effect of intensive versus standard statins on the risk of stroke in patients with coronary artery syndromes (CAS). PubMed, Embase, the Cochrane library, and clinicaltrials.gov were searched, and the retrieved studies were undertaken for randomized controlled tria...
Autores principales: | Xie, Chengjuan, Zhu, Mingyu, Hu, Ying, Wang, Kai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Journal of Cardiovascular Pharmacology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190051/ https://www.ncbi.nlm.nih.gov/pubmed/31876797 http://dx.doi.org/10.1097/FJC.0000000000000784 |
Ejemplares similares
-
The impact of lipid-lowering medications on coronary artery plaque characteristics
por: Pulipati, Vishnu Priya, et al.
Publicado: (2021) -
Intensity of Lipid Lowering With Statin Therapy in Patients With Cerebrovascular Disease Versus Coronary Artery Disease: Insights from the PALM Registry
por: Xian, Ying, et al.
Publicado: (2019) -
High-intensity lipid-lowering regimens in patients with stable coronary artery disease: the intriguing question of all-cause mortality
por: Danchin, Nicolas, et al.
Publicado: (2019) -
Intensive lipid lowering agents and coronary atherosclerosis: Insights from intravascular imaging
por: Di Giovanni, Giuseppe, et al.
Publicado: (2022) -
Associations of lipids and lipid-lowering drugs with risk of stroke: a Mendelian randomization study
por: Qin, Hao, et al.
Publicado: (2023)